2CB Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Calithera Biosciences Inc - Alpha Spread
C

Calithera Biosciences Inc
F:2CB

Watchlist Manager
Calithera Biosciences Inc
F:2CB
Watchlist
Price: 3.86 EUR -2.53% Market Closed
Market Cap: 1m EUR
Have any thoughts about
Calithera Biosciences Inc?
Write Note

Wall Street
Price Targets

2CB Price Targets Summary
Calithera Biosciences Inc

There are no price targets for 2CB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Calithera Biosciences Inc Competitors:
Price Targets
VTGN
VistaGen Therapeutics Inc
321% Upside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
65% Upside
TRDA
Entrada Therapeutics Inc
49% Upside
VXRT
Vaxart Inc
491% Upside
000403
Pacific Shuanglin Bio pharmacy Co Ltd
61% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
10% Upside
IMAB
I-Mab
585% Upside
SWTX
SpringWorks Therapeutics Inc
100% Upside

Revenue
Forecast

Revenue Estimate
Calithera Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Calithera Biosciences Inc

Operating Income forecast
is not available for
Calithera Biosciences Inc

Net Income
Forecast

Net Income Estimate
Calithera Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 2CB's stock price target?
Not Available

2CB doesn't have any price targets made by Wall Street professionals.

Back to Top